AJP - GI AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (April 16, 2009). doi:10.1152/ajpgi.00094.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/G90    most recent
00094.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lam, I. P.-Y.
Right arrow Articles by Chow, B. K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lam, I. P.-Y.
Right arrow Articles by Chow, B. K. C.
Submitted on March 11, 2009
Revised on April 1, 2009
Accepted on April 10, 2009

Bile Acids Inhibit Duodenal Secretin Expression via Orphan Nuclear Receptor Small Heterodimer Partner (SHP)

Ian Pak-Yan Lam1, Leo T. O. Lee1, Hueng-Sik Choi2, Gianfranco Alpini3, and Billy K. C. Chow4*

1 University of Hong Kong
2 Chonnam National University
3 Central Texas Veterans Health Care System and Texas A & M Health Science Center College of Medicine
4 The University of Hong Kong

* To whom correspondence should be addressed. E-mail: bkcc{at}hkusua.hku.hk.

Small heterodimer partner (SHP) is an orphan nuclear receptor which gene expression can be up-regulated by bile acids. It regulates its target genes by repressing the transcriptional activities of other nuclear receptors including NeuroD, which has been shown to regulate secretin gene expression. Here, we evaluated the regulation on duodenal secretin gene expression by SHP and selected bile acids (cholic acid (CA) and chenodeoxycholic acid (CDCA)). In vitro treatment of CDCA or fexaramine elevated SHP transcript level and occupancy on secretin promoter. The increase in SHP level, induced by bile acid treatment or overexpression, reduced secretin gene expression, while this gene inhibitory effect was reversed by silencing of endogenous SHP. In in vivo studies, double-immunofluorescence staining demonstrated the coexpression of secretin and SHP in mouse duodenum. Feeding mice with 1% CA-enriched rodent chow resulted in up-regulation of SHP and a concomitant decrease in secretin transcript and protein levels in duodenum comparing to control group fed with normal chow. 5% cholestyramine (CY)-enriched diet led to a decrease in SHP level and a corresponding increase in secretin expression. Overall, this study showed that bile acids via SHP inhibit duodenal secretin gene expression. As secretin is a key hormone that stimulates bile flow in cholangiocytes, this pathway thus provides a novel means to modulate secretin-stimulated choleresis in response to intraduodenal bile acids.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.